Europe — EMA
Bupivacaïne Pour Rachianesthesie Aguettant (Bupivacaine Hydrochloride Monohydrate)
Bupivacaine Hydrochloride Monohydrate is a local anesthetic used for intrathecal administration. It provides targeted pain relief during medical procedures. Lea
Request sourcing
What is Bupivacaine Hydrochloride Monohydrate?
Bupivacaine Hydrochloride Monohydrate is a local anesthetic used for intrathecal administration. It provides targeted pain relief during medical procedures. Learn about its uses, effects, and precautions.
What is Bupivacaine Hydrochloride Monohydrate used for?
Bupivacaine Hydrochloride Monohydrate is primarily used for intrathecal anesthesia, offering localized pain relief during surgical procedures. It is often administered to manage pain in specific areas of the body, making it a valuable tool in various medical settings. This medication is designed to provide effective pain management during intrathecal use.
What are the side effects of Bupivacaine Hydrochloride Monohydrate?
When administered intrathecally, Bupivacaine Hydrochloride Monohydrate typically provides localized numbness and pain relief. Patients may experience a reduction in sensation in the targeted area, which is a common effect of local anesthetics. The duration and intensity of these effects can vary depending on individual factors.
What precautions apply to Bupivacaine Hydrochloride Monohydrate?
Bupivacaine Hydrochloride Monohydrate should be handled with care and administered by healthcare professionals. It is important to follow proper dosage guidelines and monitor patients for any adverse reactions. Patients with a history of allergic reactions to local anesthetics should inform their healthcare provider before use.
What does Bupivacaine Hydrochloride Monohydrate interact with?
Bupivacaine Hydrochloride Monohydrate may interact with other medications, including certain pain relievers and blood thinners. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other central nervous system depressants should be avoided during treatment.



